THBS2 and pulmonary fibrosis: Importantly, the present study suggests that miR-17-5p-loaded hESC-exo prevent pulmonary fibrosis by directly binding to Thbs2, which may offer a new therapeutic strategy for IPF, a disease currently lacking effective treatment.